$ERAS

Erasca, Inc.
Stock
14.52
+0.58 · +4.12%
WATCH

Analyst Views on $ERAS

0 Analysts Bull · 1 Analyst Neutral · 0 Analysts Bear
Neutral 1
Editorial Representation of Brent Kochuba Brent Kochuba NEUTRAL Neutral
Month 4h

$ERAS options pricing anticipates a large stock move heading into the November 20 clinical data announcement, without specifying an upside or downside direction.

Comments

0 REMARKS